Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory

Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory

Abstract Coronavirus disease 2019 (COVID-19) is associated with extreme inflammatory response, disordered hemostasis and high thrombotic risk. A high incidence of thromboembolic events has been reported despite thromboprophylaxis, raising the question of a more effective anticoagulation. First-line...

Full description

Bibliographic Details
Main Authors: M. Hardy, T. Lecompte, J. Douxfils, S. Lessire, J. M. Dogné, B. Chatelain, S. Testa, I. Gouin-Thibault, Y. Gruel, R. L. Medcalf, H. ten Cate, G. Lippi, F. Mullier
Format: Article
Language:English
Published: BMC 2020-09-01
Series:Thrombosis Journal
Subjects:
Thrombosis
D-dimers
Anticoagulation
COVID-19
Coagulopathy
Hemostasis
Online Access:http://link.springer.com/article/10.1186/s12959-020-00230-1

Internet

http://link.springer.com/article/10.1186/s12959-020-00230-1

Similar Items